All probes

ML224 : TSHR (Thyroid Stimulating Hormone Receptor) Inverse agonist

ML224

ML224

Target Name

Thyroid Stimulating Hormone Receptor

Target Alias

TSHR

Target Class

G-protein Coupled Receptor

Mechanism of Action

Inverse agonist of TSHR

Biology / Disease Relevance

Thyroid homeostasis, TSHR biology

In vitro activity
TSHR bioassay (IC50)
2300 nM
Cellular activity
TSHR ELISA assay (IC50)
6000 nM

Target Information

Thyroid Stimulating Hormone (TSH) is a heterodimeric glycoprotein hormone that regulates thyroid homeostasis upon interaction with the TSH receptor (TSHR). TSH binds to the TSH receptor, which couples preferentially to the G-alpha (s) (Gs) protein, resulting in activation of adenylate cyclase and an increase in cyclic adenosine 3’, 5’ monophosphate (cAMP). Preliminary structure activity relationship studies led to the discovery of a selective TSHR inverse agonist, ML224, which could be a useful tool for studying TSHR functions; it could also be a potential lead for development of drugs to treat TSHR-mediated hyperthyroidism caused by constitutively activating mutations or stimulating auto-antibodies associated with Graves’ disease.

Properties

ML224

NCGC00242364

Physical & chemical properties
Molecular Weight 525.6 g/mol
Molecular Formula C31H31N3O5
cLogP 4.7
PSA 93 Ų
Storage
Solubility
CAS Number 1338824-21-7

SMILES:
COC1=C(COC2=C(C)C=C(NC(C)=O)C=C2C)C=C(C3NC4=C(C(N3CC5=CC=CO5)=O)C=CC=C4)C=C1

InChI:
1S/C31H31N3O5/c1-19-14-24(32-21(3)35)15-20(2)29(19)39-18-23-16-22(11-12-28(23)37-4)30-33-27-10-6-5-9-26(27)31(36)34(30)17-25-8-7-13-38-25/h5-16,30,33H,17-18H2,1-4H3,(H,32,35)

InChIKey:
BFTSWGYWHRJVNI-UHFFFAOYSA-N

Activity

Summary activity statement /

Thyroid Stimulating Hormone (TSH) is a heterodimeric glycoprotein hormone that regulates thyroid homeostasis upon interaction with the TSH receptor (TSHR). TSH binds to the TSH receptor, which couples preferentially to the G-alpha (s) (Gs) protein, resulting in activation of adenylate cyclase and an increase in cyclic adenosine 3’, 5’ monophosphate (cAMP)1. TSHR exhibits basal (agonist-independent or constitutive) signaling, and the current state of the art is lacking any small-molecule TSHR inverse agonists. ML224 (SID 109967290; CID 50897809) is a member of a series of TSHR modulators and selectively inhibits TSH-stimulated cAMP production with an IC50 = 2.3 μM, and TSHR basal activity with an IC50 = 6 μM. This probe can be used to study TSHR functions in vitro; it could also be used as a lead for development of drugs to treat hyperthyroidism caused by TSHR constitutively activating mutations or stimulating auto-antibodies associated with Graves’ disease.

In vitro activity - Selectivity Assay

Bioassay ML224 (IC50)

TSHR

2300 nM

LHR (Anti-Target)

Inactive

FSHR (Anti-Target)

Inactive

Summary /

ML209 is found to have > 20 fold selective against the TSHR vs. other hormone receptor.

Figure 1. Activity of ML224 at the three glycoprotein hormone receptors in the ELISA cAMP assays. The compound is selective towards the TSHR.

 

Cellular activity - Human Thyrocytes and HEK-EM 293 cell

Summary /

TSHR antagonists from this series were found to be active against the THSH expressed stably in HEK-EM 293 cells and primary cultures of human thyrocytes (AID 504380) . No toxicity has been seen in in vitro studies in HEK cells stably expressing the TSHR and in primary cultures of human thyrocytes.

In vitro activity - Mechanism of Action Study

Summary /

A Schild analysis of TSH-stimulated cAMP production shows that CID 2887926 acts as a competitive antagonist of TSH signaling. The Schild plot of these data was linear with a slope of 1.0, which is typical for a competitive ligand. CID 2887926 had no effect on [125I] TSH binding to TSHRs on the surface of HEK-EM 293 cells. A lack of effect of CID 2887926 on TSH binding was expected because we have previously shown that CID 25246343, a TSHR agonist that contains the same scaffold as CID 2887926, does not affect TSH binding and provided evidence that it binds in the transmembrane domain of TSHR24. We assume that CID 2887926 and other TSHR antagonists from these series bind in the serpentine region of TSHR.